Evidence map›Paper›PMID 30060536›Full record

ReviewMolecules (Basel, Switzerland)2018

Lignin-Derived Biomaterials for Drug Release and Tissue Engineering.

Markus Witzler, Abla Alzagameem, Michel Bergs, Basma El Khaldi-Hansen, Stephanie E Klein, Dorothee Hielscher, Birgit Kamm, Judith Kreyenschmidt, Edda Tobiasch, Margit Schulze

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Exosomes: A New Hope for Angiogenesis-Mediated Bone Regeneration.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Spheronized drug microcarrier system from canola straw lignin.Science and technology of advanced materials · 2023
    Article
  17. Plant Polysaccharides in Engineered Pharmaceutical Gels.Bioengineering (Basel, Switzerland) · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Markus WitzlerDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. markus.witzler@h-brs.de.ORCID 0000-0002-0468-3051
Abla AlzagameemDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. abla.alzagameem@h-brs.de.
Michel BergsDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. michel.bergs@h-brs.de.
Basma El Khaldi-HansenDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. basma.elkhaldi-hansen@h-brs.de.
Stephanie E KleinDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. stephanie.klein@h-brs.de.
Dorothee HielscherDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. dorothee.hielscher@h-brs.de.
Birgit KammFaculty of Environment and Natural Sciences, Brandenburg University of Technology BTU Cottbus-Senftenberg, Platz der Deutschen Einheit 1, D-03046 Cottbus, Germany. kamm@btu-cottbus-senftenberg.de.
Judith KreyenschmidtRheinische Friedrich Wilhelms-University Bonn, Katzenburgweg 7-9, D-53115 Bonn, Germany. kamm@btu-cottbus-senftenberg.de.
Edda TobiaschDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. edda.tobiasch@h-brs.de.
Margit SchulzeDepartment of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, von-Liebig-Str. 20, D-53359 Rheinbach, Germany. margit.schulze@h-brs.de.ORCID 0000-0002-8975-1753

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renewable resources are gaining increasing interest as a source for environmentally benign biomaterials, such as drug encapsulation/release compounds, and scaffolds for tissue engineering in regenerative medicine. Being the second largest naturally abundant polymer, the interest in lignin valorization for biomedical utilization is rapidly growing. Depending on its resource and isolation procedure, lignin shows specific antioxidant and antimicrobial activity. Today, efforts in research and industry are directed toward lignin utilization as a renewable macromolecular building block for the preparation of polymeric drug encapsulation and scaffold materials. Within the last five years, remarkable progress has been made in isolation, functionalization and modification of lignin and lignin-derived compounds. However, the literature so far mainly focuses lignin-derived fuels, lubricants and resins. The purpose of this review is to summarize the current state of the art and to highlight the most important results in the field of lignin-based materials for potential use in biomedicine (reported in 2014⁻2018). Special focus is placed on lignin-derived nanomaterials for drug encapsulation and release as well as lignin hybrid materials used as scaffolds for guided bone regeneration in stem cell-based therapies.

Indexed as

Biocompatible MaterialsDrug LiberationLigninNanostructuresTissue EngineeringTissue ScaffoldsBiocompatible MaterialsLigninbiomaterialbone regenerationdrug releasehydrogelligninmultivariate data processingosteogenesisscaffoldsstem cellstissue engineering

Identifiers

PMID30060536
PMCPMC6222784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.